Insider Transactions Reported by 9 Insiders of Apimeds Pharmaceuticals US, Inc.

Symbol
APUS on NYSE
Location
Matawan, NJ

There are no Buy or Sell transactions made by insiders since 15 Mar 2025

Apimeds Pharmaceuticals US, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Inscobee Inc. 10%+ Owner $8,805,900 12 May 2025
Erik C. Emerson Chief Executive Officer, Director $1,312,500 15 Oct 2025
Christopher Kim Chairman and CMO, Director $485,625 15 Oct 2025
Mark Corrao Chief Financial Officer 04 Mar 2025
Carol A. O'Donnell Director 11 Nov 2025
Jakap Koo Director 11 Nov 2025
Elona Kogan Director 11 Nov 2025
Hankil Yoon Director 11 Nov 2025
Bennett Weintraub Director 11 Nov 2025

Recent Insider Transactions by Companies or Individuals for Apimeds Pharmaceuticals US, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Jakap Koo APUS Stock Option (right to buy) Award 10,000 10,000 11 Nov 2025 Direct
Hankil Yoon APUS Stock Option (right to buy) Award 10,000 10,000 11 Nov 2025 Direct
Bennett Weintraub APUS Stock Option (right to buy) Award 10,000 10,000 11 Nov 2025 Direct
Elona Kogan APUS Stock Option (right to buy) Award 10,000 10,000 11 Nov 2025 Direct
Carol A. O'Donnell APUS Stock Option (right to buy) Award 10,000 10,000 11 Nov 2025 Direct
Elona Kogan APUS Stock Option (right to buy) Award 3,000 3,000 15 Oct 2025 Direct
Carol A. O'Donnell APUS Stock Option (right to buy) Award 3,000 3,000 15 Oct 2025 Direct
Jakap Koo APUS Stock Option (right to buy) Award 3,000 3,000 15 Oct 2025 Direct
Bennett Weintraub APUS Stock Option (right to buy) Award 3,000 3,000 15 Oct 2025 Direct
Christopher Kim APUS Stock Option (right to buy) Award 3,000 3,000 15 Oct 2025 Direct
Hankil Yoon APUS Stock Option (right to buy) Award 3,000 3,000 15 Oct 2025 Direct
Erik C. Emerson APUS Stock Option (right to buy) Award 215,000 215,000 15 Oct 2025 Direct
Elona Kogan APUS Stock Option (right to buy) Award 5,780 5,780 16 May 2025 Direct
Hankil Yoon APUS Stock Option (right to buy) Award 5,780 5,780 16 May 2025 Direct
Carol A. O'Donnell APUS Stock Option (right to buy) Award 5,780 5,780 16 May 2025 Direct
Christopher Kim APUS Common Stock, par value $0.01 per share Award 909.1% 250,000 277,500 16 May 2025 Direct
Erik C. Emerson APUS Common Stock, par value $0.01 per share Award 750,000 750,000 16 May 2025 Direct
Erik C. Emerson APUS Stock option (right to buy) Award 347,279 347,279 16 May 2025 Direct
Bennett Weintraub APUS Stock Option (right to buy) Award 5,780 5,780 16 May 2025 Direct
Jakap Koo APUS Stock Option (right to buy) Award 5,780 5,780 16 May 2025 Direct
Christopher Kim APUS Common Stock, par value $0.01 per share Purchase 39.1% 7,730 27,500 14 May 2025 Direct
Christopher Kim APUS Common Stock, par value $0.01 per share Purchase 19,770 19,770 13 May 2025 Direct
Inscobee Inc. APUS Common Stock, par value $0.01 per share Conversion of derivative security 5.8% 115,131 2,099,747 12 May 2025 Direct
Inscobee Inc. APUS Convertible Promissory Note Conversion of derivative security 0 0 12 May 2025 Direct
Jakap Koo APUS Common Stock, par value $0.01 per share Purchase 4.63% 28,500 643,885 12 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.